NASDAQ:CLOV Clover Health Investments Q2 2026 Earnings Report $4.68 -0.14 (-2.90%) Closing price 04:00 PM EasternExtended Trading$4.66 -0.02 (-0.34%) As of 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Clover Health Investments EPS ResultsActual EPSN/AConsensus EPS $0.05Beat/MissN/AOne Year Ago EPSN/AClover Health Investments Revenue ResultsActual RevenueN/AExpected Revenue$728.27 millionBeat/MissN/AYoY Revenue GrowthN/AClover Health Investments Announcement DetailsQuarterQ2 2026Date8/5/2026TimeAfter Market ClosesConference Call DateWednesday, August 5, 2026Conference Call Time5:00PM ETConference Call ResourcesEarnings HistoryCompany Profile Clover Health Investments Earnings HeadlinesClover Health Investments (CLOV) Faces A Valuation Test Ahead Of August EarningsJuly 11, 2026 | finance.yahoo.comIs Clover Health Investments (CLOV) Reasonable After Its 3.8x Run?July 10, 2026 | finance.yahoo.comSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in 50 years - and it has nothing to do with a single stock. According to multiple Wall Street banks, a coming crisis could keep your portfolio in the red for 10 years or longer. Keith Kaplan, CEO of TradeSmith, is sharing what you can do to protect your wealth before it hits.July 15 at 1:00 AM | TradeSmith (Ad)Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026July 9, 2026 | globenewswire.comClinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization ...July 7, 2026 | markets.businessinsider.comClinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-UpJuly 7, 2026 | globenewswire.comSee More Clover Health Investments Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Clover Health Investments? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Clover Health Investments and other key companies, straight to your email. Email Address About Clover Health InvestmentsClover Health Investments (NASDAQ:CLOV) is a technology-driven healthcare company specializing in Medicare Advantage plans for senior populations. The company combines insurance coverage with a proprietary software platform to improve care coordination, outcomes tracking and cost management. By leveraging data analytics, Clover Health aims to deliver personalized care pathways and preventive interventions for its members. At the core of Clover’s offering is its Clover Assistant platform, which aggregates clinical and claims data from multiple sources to create real-time insights for physicians and care teams. This platform flags gaps in care, offers evidence-based treatment suggestions and facilitates member outreach to ensure adherence to preventive screenings and chronic condition management. Clover’s insurance products cover hospitalization, outpatient care, prescription drug benefits and various supplemental services, including telehealth and transportation assistance. Founded in 2014 by Vivek Garipalli and Kris Gale and headquartered in Jersey City, New Jersey, Clover Health has expanded its Medicare Advantage footprint across several U.S. states. The company serves beneficiaries in urban and rural markets, with operations spanning regions such as the Northeast, Southeast and Midwest. Under the leadership of its co-founders, Clover continues to invest in data science, artificial intelligence and member engagement tools to drive clinical quality improvements and cost efficiencies throughout its network.View Clover Health Investments ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Why Johnson & Johnson’s Earnings Dip Looks Like a Buying OpportunityApple’s AI Toll Booth Thesis Faces Its Biggest Test Yet Before EarningsWhy ASML’s AI Monopoly Is Still Getting StrongerAlphabet’s AI Spending Question Looms Over Q2 EarningsCPI Comes In Cool: Why It Could Revive These 3 Rate-Sensitive StocksPlot Twist: 12 States Could Stall the Paramount-Warner Bros. Discovery Mega-MergerMarriott vs. Viking: Why the Better Quarter Doesn't Mean the Better Decade Upcoming Earnings GE Aerospace (7/16/2026)Taiwan Semiconductor Manufacturing (7/16/2026)Netflix (7/16/2026)Prologis (7/16/2026)State Street (7/16/2026)U.S. Bancorp (7/16/2026)Abbott Laboratories (7/16/2026)Intuitive Surgical (7/16/2026)UnitedHealth Group (7/16/2026)Fifth Third Bancorp (7/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
